Issue Date | Title | Involved Person(s) |
Nov-2019 | Wirken Antidepressiva bei schweren Depressionen besser als bei leichten? | Hengartner, Michael Pascal; Plöderl, Martin |
22-Aug-2019 | Antidepressant withdrawal : the tide is finally turning | Hengartner, Michael Pascal; Davies, James; Read, John |
Jun-2019 | Antidepressiva wirken! Oder doch nicht? | Plöderl, Martin; Hengartner, Michael Pascal |
Jun-2019 | Eine methodenkritische Evaluation der biomedizinischen Depressionsforschung : wie zuverlässig und praxisrelevant sind vielbeachtete neurobiogenetische Befunde? | Hengartner, Michael Pascal |
19-May-2019 | We should cure the ills of society to combat the depression epidemic | Hengartner, Michael Pascal |
2019 | Scientific debate instead of beef : challenging misleading arguments about the efficacy of antidepressants | Hengartner, Michael Pascal |
2019 | Clinical guidelines on antidepressant withdrawal urgently need updating | Davies, James; Read, John; Hengartner, Michael Pascal; Cosci, Fiammetta; Fava, Giovanni; Chouinard, Guy; van Os, Jim; Nardi, Antonio; Gøtzsche, Peter; Groot, Peter; Offidani, Emanuela; Timimi, Sami; Moncrieff, Joanna; Spada, Marcantonio; Guy, Anne |
2019 | Is there a genuine placebo effect in acute depression treatments? : a reassessment of regression to the mean and spontaneous remission | Hengartner, Michael Pascal |
2019 | How long does antidepressant withdrawal typically last? | Hengartner, Michael Pascal; Davies, James; Read, John |
2019 | Guidelines for the pharmacological acute treatment of major depression : conflicts with current evidence as demonstrated with the German S3-guidelines | Plöderl, Martin; Hengartner, Michael Pascal |
2019 | Long-term outcomes of trials in the National Institute for Health and Care Excellence depression guideline | McPherson, Susan; Hengartner, Michael Pascal |
2019 | What are the chances for personalised treatment with antidepressants? : detection of patient-by-treatment interaction with a variance ratio meta-analysis | Plöderl, Martin; Hengartner, Michael Pascal |
2019 | Reply to the letter to the editor : “newer-generation antidepressants and suicide risk : thoughts on Hengartner and Plöderl’s re-analysis” | Hengartner, Michael Pascal; Plöderl, Martin |
2019 | Commentary on “The challenge of transforming the diagnostic system of personality disorders” | Hopwood, C. J.; Krueger, R. F.; Watson, D.; Widiger, T. A.; Althoff, R. R.; Ansell, E. B.; Bach, B.; Bagby, R. M.; Blais, M. A.; Bornovalova, M. A.; Chmielewski, M.; Cicero, D. C.; Conway, C.; De Clerq, B.; De Fruyt, F.; Docherty, A. R.; Eaton, N. R.; Edens, J. F.; Forbes, M. K.; Forbush, K. T.; Hengartner, M. P.; Ivanova, M. Y.; Leising, D.; Lukowitsky, M. R.; Lynam, D. R.; Markon, K. E.; Miller, J. D.; Morey, L. C.; Mullins-Sweatt, S. N.; Ormel, J.; Patrick, C. J.; Pincus, A. L.; Ruggero, C.; Samuel, D. B.; Sellbom, M.; Tackett, J. L.; Thomas, K. M.; Trull, T. J.; Vachon, D. D.; Waldman, I. D.; Waszczuk, M. A.; Waugh, M. H.; Wright, A. G.C.; Yalch, M. M.; Zald, D. H.; Zimmermann, J. |
29-Aug-2018 | What is the threshold for a clinical minimally important drug effect? | Hengartner, Michael Pascal |